Trials Sponsors Conditions Drugs Pricing

Conditions

Low Back Pain, Mechanical Lumbar Disc Herniation Sciatica Spine Stiffness

Keywords

Disc Prolapsesacroiliac jointInjectionUltrasound

Outcome Measures

Primary Outcomes (3)

Pain assessment by visual analogue scale.
Visual analogue scale, 0 means no pain and 10 means the maximum possible pain.
at baseline 0 time, after 2 weeks and after 16 weeks
Spine mobility, finger tip to floor test
comparison to the intial values with each visit to detect changes with no definite references.
Baseline 0 time, after 2 weeks and after 16 weeks
Oswestry disability index
0 value means no disability and 100 means complete disability
Baseline 0 time, after 2 weeks and after 16 weeks

Study Arms (2)

Sacroiliac joint injection group

ACTIVE COMPARATOR

The active group will receive bilateral sacroiliac joint injection of 1 mL 2 % lidocaine hydrochloride (xylocaine, AstraZeneca) mixed with triamcinolone 40 milligrams (Kenacort, Bristol Myers Squip) under ultrasound guidance.

Procedure: Bilateral SIJ injection

control group

NO INTERVENTION

The other group will not receive the sacroiliac joint injection

Interventions

Bilateral SIJ injectionProcedure

under US guidance a 22G spinal needle, where 1 mL 2 % lidocaine hydrochloride (xylocaine, AstraZeneca) mixed with triamcinolone 40 milligrams (Kenacort, Bristol Myers Squip) will be injected in each SIJ

Sacroiliac joint injection group

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Lumbar disc prolapse diagnosed by either MRI or CT were included.
All of them aged \> 18 years

Sponsors & Collaborators

Sohag University
Otherlead

Study Sites (1)

Sohag university

Sohag, 82749, Egypt

MeSH Terms

Conditions

Intervertebral Disc DisplacementSciaticaLow Back Pain

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal DiseasesHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSciatic NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNeuralgia

Enrollment

86 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: DOUBLE
Who Masked: INVESTIGATOR, OUTCOMES ASSESSOR
Purpose: OTHER
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Associate professor

Study Record Dates

First Submitted

March 25, 2020

First Posted

March 30, 2020

Study Start

March 15, 2020

Actual (reported)

Bilateral Sacroiliac Joint (SIJ) Injection in Lumbar Disc Prolapse

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (3)

Study Arms (2)

Sacroiliac joint injection group

control group

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (3)

Study Arms (2)

Sacroiliac joint injection group

control group

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations